Toronto Rehabilitation Institute - Rumsey Center
Welcome,         Profile    Billing    Logout  
 16 Trials 
21 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Brooks, Dina
NCT05435963: Impact of Pulmonary Rehabilitation on Loneliness in COPD

Recruiting
N/A
45
Canada
Pulmonary rehabilitation (PR)
McMaster University
Loneliness
09/23
12/23
NCT04767074: A Non-pharmacological Cough Control Therapy

Recruiting
N/A
24
Canada
Non-pharmacological Cough control Therapy, Cough Control therapy
West Park Healthcare Centre, St. Joseph's Healthcare Hamilton
Cough, ILD, Pulmonary Disease, Pulmonary Fibrosis
12/24
12/24
STS24, NCT06479252: Comparing Centre-based, Remotely Supervised, and Self-administered STS Tests in Individuals With CRD

Recruiting
N/A
50
Canada
Sit-to-Stand Test (STS)
West Park Healthcare Centre
Chronic Lung Disease
12/24
12/24
Oh, Paul
HIIT-Stroke, NCT03006731: High Intensity Interval Training for People With Stroke Deficits

Active, not recruiting
N/A
47
Canada
High Intensity Interval Training, HIIT, Moderate Intensity Continuous Exercise, MICE, Standard
University Health Network, Toronto
Stroke
07/22
08/23
TREat-CR, NCT05075317: Time Restricted Eating and Cardiac Rehabilitation

Recruiting
N/A
60
Canada
Standard cardiac rehabilitation, Time-Restricted Eating
University of Toronto, University Health Network, Toronto
Coronary Artery Disease
12/25
12/25
NCT04455867: The Sunnybrook Type 2 Diabetes Study

Recruiting
N/A
500
Canada
Diabetes Exercise and Healthy Lifestyle Program, Outpatient care
Sunnybrook Health Sciences Centre, University Health Network, Toronto, University of Toronto
Type 2 Diabetes, PreDiabetes
12/25
12/26
CORE, NCT05522959: Cardio-Oncology Rehabilitation Exercise

Recruiting
N/A
100
Canada
University of Toronto, Toronto Rehabilitation Institute
Breast Cancer
12/24
12/24
Black, Sandra
TRAILRUNNER-ALZ 3, NCT06653153: A Study of Remternetug (LY3372993) in Early Alzheimer's Disease

Recruiting
3
1200
Europe, Canada, Japan, US, RoW
Remternetug, LY3372993, Placebo
Eli Lilly and Company
Alzheimer's Disease
04/29
10/30
ENVISION, NCT05310071 / 2022-001671-14: A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Terminated
3
1027
Europe, Canada, Japan, US, RoW
Aducanumab, BIIB037, Aducanumab-avwa, Aduhelm, Placebo
Biogen, Biogen Idec Research Limited
Alzheimer's Disease
08/24
08/24
SARTAN-AD, NCT02085265: Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

Recruiting
2
150
Canada
Perindopril, Coversyl, Telmisartan, Micardis
Sunnybrook Health Sciences Centre, Alzheimer's Drug Discovery Foundation, Weston Brain Institute
Alzheimer's Disease
09/23
09/23
CAMAROS, NCT04789616: The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke

Recruiting
2
120
Canada
Maraviroc, Celsentri, Exercise Program, Placebo, "Sugar" Pill, Activity Sensor, Motor Learning
University of Calgary, University Health Network, Toronto, University of California, Los Angeles, Sunnybrook Health Sciences Centre, University of British Columbia, Memorial University of Newfoundland, Dalhousie University, Parkwood Hospital, London, Ontario, Riverview Health Centre Foundation, The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Stroke
12/25
12/25
COMPASS-ND, NCT03402919: Comprehensive Assessment of Neurodegeneration and Dementia

Recruiting
N/A
2300
Canada
McGill University, Canadian Institutes of Health Research (CIHR), Alzheimer Society of Canada, Sanofi, New Brunswick Health Research Foundation, Saskatchewan Health Research Foundation, Women's Brain Health Initiative, Michael Smith Foundation for Health Research, Alzheimer's Research UK, Alberta Prion Research Institute, Nova Scotia Health Research Foundation, Eli Lilly and Company, Canadian Nurses Foundation (CNF), Ontario Brain Institute, Consortium pour l'Identification precoce du Maladie Alzheimer du Quebec, Pfizer, Canadian Consortium on Neurodegeneration in Aging
Dementia
09/23
09/23
CRND TorCA, NCT06529744: Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

Recruiting
N/A
500
Canada
University Health Network, Toronto, Sunnybrook Health Sciences Centre, Baycrest, Centre for Addiction and Mental Health, Toronto Dementia Research Alliance (TDRA), University of Toronto
Dementia, Alzheimer Disease, Dementia with Lewy Bodies, Vascular Dementia, Frontotemporal Dementia, Mild Cognitive Impairment, Corticobasal Syndrome, Progressive Supranuclear Palsy, Parkinson Disease, Primary Progressive Aphasia
11/26
11/27
REPHRASE, NCT05107882: Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

Completed
N/A
466
Canada, US
Optina Diagnostics Inc., Eastern Virginia Medical School, The Cleveland Clinic, University of Washington, Sunnybrook Research Institute
Alzheimer Disease, Mild Cognitive Impairment, Mild Dementia
07/24
07/24
BEAM, NCT02524405: Brain-Eye Amyloid Memory Study

Recruiting
N/A
345
Canada
Pittsburgh Compound B [11C]-PIB
Sunnybrook Health Sciences Centre, Brain Canada, Weston Brain Institute, GE Healthcare, University Health Network, Toronto, Centre for Addiction and Mental Health, Baycrest, Unity Health Toronto, Kensington Eye Institute
Alzheimer's Disease, Mild Cognitive Impairment, Vascular Cognitive Impairment, Parkinson's Disease, Lewy Body Disease
03/25
03/25
ADNI3, NCT02854033: Alzheimer's Disease Neuroimaging Initiative 3

Recruiting
N/A
2000
Canada, US
University of Southern California, Northern California Institute of Research and Education, National Institute on Aging (NIA), Alzheimer's Therapeutic Research Institute
Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD)
12/24
12/24
MITNEC C6, NCT02330510: Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease

Completed
N/A
80
Canada
Dr. Sandra E Black
Alzheimer's Disease, Small Vessel Disease White Matter Hyperintensities Subtype, Vascular Cognitive Impairment
12/24
12/24
NCT06773416: CPAP Randomized Controlled Trial

Not yet recruiting
N/A
206
Canada
CPAP Therapy Combined with Web-Based Sleep Education for Cognitive and Sleep Health, Delayed CPAP Therapy Combined with Web-Based Sleep Education for Cognitive and Sleep Health
Sunnybrook Health Sciences Centre, Baycrest, University Health Network, Toronto, Centre for Addiction and Mental Health
Obstructive Sleep Apnea (OSA), Mild Cognitive Impairment (MCI), Cognitive Decline Prevention in Pre-frail Older Adults
09/27
01/28
NCT01800214: The Sunnybrook Dementia Study

Recruiting
N/A
1600
Canada
Sunnybrook Health Sciences Centre, University of Toronto, Sunnybrook Research Institute, University of Waterloo, Baycrest
Dementia
09/25
09/25
NCT04455867: The Sunnybrook Type 2 Diabetes Study

Recruiting
N/A
500
Canada
Diabetes Exercise and Healthy Lifestyle Program, Outpatient care
Sunnybrook Health Sciences Centre, University Health Network, Toronto, University of Toronto
Type 2 Diabetes, PreDiabetes
12/25
12/26
ADNI4, NCT05617014: Alzheimer's Disease Neuroimaging Initiative 4

Recruiting
N/A
1500
Canada, US
Neuraceq, Florbetaben, Amyvid, Florbetapir, Tauvid, Flortaucipir, 18F-AV-1451, AV-1451, MK-6240, florquinitau F-18, [18F]MK-6240, NAV4694, [18F]NAV4694, [18F]AZD4694, PI-2620, [18F]PI-2620
University of Southern California, Northern California Institute of Research and Education, National Institute on Aging (NIA), Alzheimer's Therapeutic Research Institute
Mild Cognitive Impairment, Alzheimer Disease, Dementia
07/27
07/27

Download Options